InnateDB Protein
|
IDBP-727742.3
|
Last Modified
|
2014-10-13 [Report errors or provide feedback]
|
Gene Symbol
|
GATA6
|
Protein Name
|
|
Synonyms
|
|
Species
|
Homo sapiens
|
Ensembl Protein
|
ENSP00000462313
|
InnateDB Gene
|
IDBG-1469 (GATA6)
|
Protein Structure
|
|
Function |
Transcriptional activator that regulates SEMA3C and PLXNA2. Thought to be important for regulating terminal differentiation and/or proliferation. Involved in gene regulation specifically in the gastric epithelium. Involved in bone morphogenetic protein (BMP)-mediated cardiac-specific gene expression. Binds to BMP response element (BMPRE) DNA sequences within cardiac activating regions (By similarity). {ECO:0000250}.
|
Subcellular Localization |
Nucleus {ECO:0000269PubMed:19666519}.
|
Disease Associations |
Conotruncal heart malformations (CTHM) [MIM:217095]: A group of congenital heart defects involving the outflow tracts. Examples include truncus arteriosus communis, double-outlet right ventricle and transposition of great arteries. Truncus arteriosus communis is characterized by a single outflow tract instead of a separate aorta and pulmonary artery. In transposition of the great arteries, the aorta arises from the right ventricle and the pulmonary artery from the left ventricle. In double outlet of the right ventricle, both the pulmonary artery and aorta arise from the right ventricle. {ECO:0000269PubMed:19666519}. Note=The disease is caused by mutations affecting the gene represented in this entry. GATA6 mutations have been found in patients with non- syndromic persistent truncus arteriosus (PubMed:19666519). {ECO:0000269PubMed:19666519}.Atrial septal defect 9 (ASD9) [MIM:614475]: A congenital heart malformation characterized by incomplete closure of the wall between the atria resulting in blood flow from the left to the right atria. Some patients manifest tricuspid valve disease, pulmonary valve disease, and pulmonary artery hypertension. {ECO:0000269PubMed:20631719}. Note=The disease is caused by mutations affecting the gene represented in this entry.Tetralogy of Fallot (TOF) [MIM:187500]: A congenital heart anomaly which consists of pulmonary stenosis, ventricular septal defect, dextroposition of the aorta (aorta is on the right side instead of the left) and hypertrophy of the right ventricle. In this condition, blood from both ventricles (oxygen-rich and oxygen-poor) is pumped into the body often causing cyanosis. {ECO:0000269PubMed:20581743, ECO:0000269PubMed:20631719}. Note=The disease is caused by mutations affecting the gene represented in this entry.Atrioventricular septal defect 5 (AVSD5) [MIM:614474]: A congenital heart malformation characterized by a common atrioventricular junction coexisting with deficient atrioventricular septation. The complete form involves underdevelopment of the lower part of the atrial septum and the upper part of the ventricular septum; the valve itself is also shared. A less severe form, known as ostium primum atrial septal defect, is characterized by separate atrioventricular valvar orifices despite a common junction. {ECO:0000269PubMed:20581743}. Note=The disease is caused by mutations affecting the gene represented in this entry.Pancreatic agenesis and congenital heart defects (PACHD) [MIM:600001]: An autosomal dominant disease characterized by pancreatic severe hypoplasia or agenesis, diabetes mellitus, and congenital heart abnormalities including ventricular septal defect, patent ductus arteriosus, pulmonary artery stenosis, truncus arteriosus and tetralogy of Fallot. {ECO:0000269PubMed:22158542}. Note=The disease is caused by mutations affecting the gene represented in this entry.
|
Tissue Specificity |
Expressed in heart, gut and gut-derived tissues.
|
Comments |
|
Number of Interactions
|
This gene and/or its encoded proteins are associated with 11 experimentally validated interaction(s) in this database.
They are also associated with 13 interaction(s) predicted by orthology.
Experimentally validated |
Total |
11
[view]
|
Protein-Protein |
7
[view]
|
Protein-DNA |
4
[view]
|
Protein-RNA |
0
|
DNA-DNA |
0
|
RNA-RNA |
0
|
DNA-RNA |
0
|
|
Predicted by orthology |
Total |
13 [view]
|
|
|
Molecular Function |
|
Biological Process |
GO:0000122
|
negative regulation of transcription from RNA polymerase II promoter
|
GO:0003148
|
outflow tract septum morphogenesis
|
GO:0006355
|
regulation of transcription, DNA-templated
|
GO:0006366
|
transcription from RNA polymerase II promoter
|
GO:0007596
|
blood coagulation
|
GO:0008584
|
male gonad development
|
GO:0032911
|
negative regulation of transforming growth factor beta1 production
|
GO:0032912
|
negative regulation of transforming growth factor beta2 production
|
GO:0042493
|
response to drug
|
GO:0043066
|
negative regulation of apoptotic process
|
GO:0045087
|
innate immune response (InnateDB)
|
GO:0045766
|
positive regulation of angiogenesis
|
GO:0045892
|
negative regulation of transcription, DNA-templated
|
GO:0045893
|
positive regulation of transcription, DNA-templated
|
GO:0045944
|
positive regulation of transcription from RNA polymerase II promoter
|
GO:0051145
|
smooth muscle cell differentiation
|
GO:0060575
|
intestinal epithelial cell differentiation
|
GO:0060947
|
cardiac vascular smooth muscle cell differentiation
|
GO:0070848
|
response to growth factor
|
GO:0071158
|
positive regulation of cell cycle arrest
|
GO:0071456
|
cellular response to hypoxia
|
|
Cellular Component |
|
PDB ID |
|
InterPro |
IPR000679
Zinc finger, GATA-type
IPR008013
GATA-type transcription activator, N-terminal
|
PFAM |
PF00320
PF05349
|
PRINTS |
PR00619
|
PIRSF |
|
SMART |
SM00401
|
TIGRFAMs |
|
Modification |
|
SwissProt |
Q92908
|
PhosphoSite |
PhosphoSite-Q92908
|
TrEMBL |
Q05CA6
|
UniProt Splice Variant |
|
Entrez Gene |
2627
|
UniGene |
Hs.514746
|
RefSeq |
XP_005258305
|
HUGO |
HGNC:4174
|
OMIM |
601656
|
CCDS |
CCDS11872
|
HPRD |
09043
|
IMGT |
|
EMBL |
AC091588
BC027891
CH471088
D87811
EF444980
U66075
X95701
|
GenPept |
AAC50941
AAH27891
ACA05995
BAA22621
CAA64997
EAX01137
|
|
|